Last checked at 19 Dec 2006 16:52
Alliance Pharma PLC19 December 2006 For immediate release 19 December 2006 Alliance Pharma plc(the 'Company') Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6 wewould like to notify the market of the following: The Company's capital consists of 162,061,773 ordinary shares of 1p each withvoting rights. The Company holds no ordinary shares in Treasury. Therefore, the total number of voting rights in Alliance Pharma plc is162,061,773 The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in, Alliance Pharma plc under theFSA's Disclosure and Transparency Rules. For further information: Alliance Pharma plc + 44 (0) 1249 466966 John Dawson, Chief ExecutiveMaddy Scott, Finance Directorwww.alliancepharma.co.uk Buchanan Communications + 44 (0) 20 7466 5000 Lisa Baderoon This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Alliance Pharma Regulatory News (APH)
APH Share
Price
APH Share
News
APH Share
Chat
APH Share
Trades248
APH
Live RNS
APH Share
Charts
APH Level 2
Console
APH Live
Share Price
APH Broker
Ratings
APH Directors
Deals
APH Financial
Diary
APH
Fundamentals
APH Short
Positions1
APH
Media
Alliance Pharma Information
Share Price Information for Alliance Pharma (APH)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
40.50
Bid:
40.45
Ask:
40.70
Change:
0.50 (1.25%)
Spread:
0.25 (0.618%)
Open:
39.05
High:
42.60
Low:
39.05
Prev. Close:
40.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Transparency Directive
| Date | Source | Headline | |
|---|---|---|---|
| 30th Sep 2005 | 7:03 am | RNS | Misoprostol Symposium |
| 19th Sep 2005 | 7:02 am | RNS | Appointment |
| 1st Aug 2005 | 7:00 am | RNS | Notification of Shares |
| 29th Jul 2005 | 7:00 am | RNS | Distribution Agreement |
| 13th Jul 2005 | 10:11 am | RNS | Notification of Shares |
| 6th Jul 2005 | 7:00 am | RNS | Phase III Trials Approval |
| 24th Jun 2005 | 7:00 am | RNS | Notice of Interests in Shares |
| 21st Jun 2005 | 10:52 am | RNS | AGM Statement |
| 17th May 2005 | 7:00 am | RNS | Share Purchase |
| 16th May 2005 | 12:35 pm | RNS | Director Share Dealing |
| 12th May 2005 | 7:01 am | RNS | Preliminary Results |
| 11th May 2005 | 9:55 am | RNS | Share Purchase |
| 9th May 2005 | 7:00 am | RNS | Co-Promotion Agreement |
| 26th Apr 2005 | 7:02 am | RNS | Key Management Appointments |
| 30th Mar 2005 | 5:33 pm | RNS | Holding(s) in Company |
| 16th Mar 2005 | 7:00 am | RNS | Trading Statement |
| 28th Feb 2005 | 11:37 am | RNS | Director Shareholding |
| 11th Jan 2005 | 7:00 am | RNS | Clinical Trial Commences |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.